- Home
- GOSS vs HDSN Comparison
GOSS vs HDSN Comparison
Compare GOSS & HDSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- HDSN
- Stock Information
- Founded
- GOSS 2015
- HDSN 1991
- Country
- GOSS United States
- HDSN United States
- Employees
- GOSS N/A
- HDSN N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- HDSN Industrial Specialties
- Sector
- GOSS Health Care
- HDSN Consumer Discretionary
- Exchange
- GOSS Nasdaq
- HDSN Nasdaq
- Market Cap
- GOSS 347.8M
- HDSN 410.9M
- IPO Year
- GOSS 2019
- HDSN 1994
- Fundamental
- Price
- GOSS $2.47
- HDSN $10.16
- Analyst Decision
- GOSS Strong Buy
- HDSN Buy
- Analyst Count
- GOSS 4
- HDSN 4
- Target Price
- GOSS $8.50
- HDSN $8.38
- AVG Volume (30 Days)
- GOSS 3.1M
- HDSN 429.8K
- Earning Date
- GOSS 08-05-2025
- HDSN 07-30-2025
- Dividend Yield
- GOSS N/A
- HDSN N/A
- EPS Growth
- GOSS N/A
- HDSN N/A
- EPS
- GOSS N/A
- HDSN 0.40
- Revenue
- GOSS $40,237,000.00
- HDSN $224,778,000.00
- Revenue This Year
- GOSS N/A
- HDSN $3.02
- Revenue Next Year
- GOSS $30.65
- HDSN $8.53
- P/E Ratio
- GOSS N/A
- HDSN $25.67
- Revenue Growth
- GOSS N/A
- HDSN N/A
- 52 Week Low
- GOSS $0.66
- HDSN $5.11
- 52 Week High
- GOSS $2.65
- HDSN $10.34
- Technical
- Relative Strength Index (RSI)
- GOSS 68.08
- HDSN 68.01
- Support Level
- GOSS $2.38
- HDSN $9.32
- Resistance Level
- GOSS $2.65
- HDSN $10.34
- Average True Range (ATR)
- GOSS 0.15
- HDSN 0.24
- MACD
- GOSS 0.03
- HDSN 0.01
- Stochastic Oscillator
- GOSS 76.67
- HDSN 82.35
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About HDSN Hudson Technologies Inc.
Hudson Technologies Inc is an American industrial products manufacturer. It develops products which are mainly used in commercial air conditioning, industrial processing, and refrigeration systems. The company products include refrigerant and industrial gases, refrigerant management services and RefrigerantSide services, which consist of system decontamination. These are performed at customer's site using its Zugibeast system, which is a fast and portable system and allows the R-Side services team to accelerate critical services while saving customers time, money and aggravation. The company also owns a web-based real-time monitoring service which is used in the facility's refrigeration systems and other energy systems.